CLLS
Price
$1.58
Change
-$0.07 (-4.24%)
Updated
Jul 3 closing price
Capitalization
165.09M
24 days until earnings call
DTIL
Price
$4.34
Change
+$0.21 (+5.08%)
Updated
Jul 3 closing price
Capitalization
48.12M
Interact to see
Advertisement

CLLS vs DTIL

Header iconCLLS vs DTIL Comparison
Open Charts CLLS vs DTILBanner chart's image
Cellectis SA
Price$1.58
Change-$0.07 (-4.24%)
Volume$37.41K
Capitalization165.09M
Precision BioSciences
Price$4.34
Change+$0.21 (+5.08%)
Volume$61.35K
Capitalization48.12M
CLLS vs DTIL Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. DTIL commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Buy and DTIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CLLS: $1.58 vs. DTIL: $4.34)
Brand notoriety: CLLS and DTIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 74% vs. DTIL: 22%
Market capitalization -- CLLS: $165.09M vs. DTIL: $48.12M
CLLS [@Biotechnology] is valued at $165.09M. DTIL’s [@Biotechnology] market capitalization is $48.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileDTIL’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • DTIL’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 5 TA indicator(s) are bullish while DTIL’s TA Score has 5 bullish TA indicator(s).

  • CLLS’s TA Score: 5 bullish, 5 bearish.
  • DTIL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CLLS and DTIL are a good buy in the short-term.

Price Growth

CLLS (@Biotechnology) experienced а +6.20% price change this week, while DTIL (@Biotechnology) price change was +4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CLLS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($165M) has a higher market cap than DTIL($48.1M). DTIL YTD gains are higher at: 13.911 vs. CLLS (-12.222). DTIL has higher annual earnings (EBITDA): -16.57M vs. CLLS (-32.49M). CLLS has more cash in the bank: 242M vs. DTIL (77.2M). DTIL has less debt than CLLS: DTIL (29.7M) vs CLLS (91.8M). DTIL has higher revenues than CLLS: DTIL (51.1M) vs CLLS (47.6M).
CLLSDTILCLLS / DTIL
Capitalization165M48.1M343%
EBITDA-32.49M-16.57M196%
Gain YTD-12.22213.911-88%
P/E RatioN/A4.38-
Revenue47.6M51.1M93%
Total Cash242M77.2M313%
Total Debt91.8M29.7M309%
FUNDAMENTALS RATINGS
CLLS vs DTIL: Fundamental Ratings
CLLS
DTIL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4985
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (23) in the Biotechnology industry is in the same range as DTIL (30). This means that CLLS’s stock grew similarly to DTIL’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DTIL (100). This means that CLLS’s stock grew similarly to DTIL’s over the last 12 months.

CLLS's SMR Rating (97) in the Biotechnology industry is in the same range as DTIL (97). This means that CLLS’s stock grew similarly to DTIL’s over the last 12 months.

CLLS's Price Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for DTIL (85). This means that CLLS’s stock grew somewhat faster than DTIL’s over the last 12 months.

CLLS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as DTIL (100). This means that CLLS’s stock grew similarly to DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLLSDTIL
RSI
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
82%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
68%
Bearish Trend 5 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRSB16.000.68
+4.44%
FIRST RESOURCE BANCORP INC.
SZKMY46.650.70
+1.52%
Suzuki Motor Co.
FCRM0.05N/A
N/A
Franklin Credit Management Corp.
OTGLF74.10N/A
N/A
CD Projekt SA
ADLRF13.80N/A
N/A
ALARIS EQUITY PARTNERS INCOME TR

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-4.24%
SLN - CLLS
43%
Loosely correlated
-2.99%
PMVP - CLLS
39%
Loosely correlated
+8.18%
TGTX - CLLS
36%
Loosely correlated
+1.18%
CLGN - CLLS
33%
Poorly correlated
-2.54%
DTIL - CLLS
32%
Poorly correlated
+1.88%
More

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with JBPHF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
+1.88%
JBPHF - DTIL
47%
Loosely correlated
N/A
RENB - DTIL
36%
Loosely correlated
+3.44%
MURA - DTIL
33%
Loosely correlated
+2.79%
CLLS - DTIL
32%
Poorly correlated
-4.24%
LEGN - DTIL
30%
Poorly correlated
-0.75%
More